Bill Summary

by Gruters

International Drug Reference Pricing; Providing legislative policy; requiring prescription drug manufacturer permitholders to annually report certain international price data to the Agency for Health Care Administration; providing for administrative enforcement by a specified fine and permit suspension; requiring the agency to contract with an entity to designate reference price source countries and establish the reference prices for prescription drugs based on certain criteria; requiring the agency contractor to reevaluate the designated reference prices source countries annually and revise, as needed, etc. Effective Date: 7/1/2024

» S Health Policy
   S Appropriations Committee on Health and Human Services
   S Fiscal Policy